CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline ATRO Q1 2026 Earnings EPS Beats Estimates by 282 Amid Stable Operations YSG Q4 2025 Earnings Positive EPS but Revenue Transparency Remains Limited Teva Q1 2026 Earnings EPS Beats Estimates Stock Slips on Mixed Market Sentiment Conduent Q1 2026 Earnings EPS Surprises Significantly Above Estimates Stock Surges ThredUp TDUP Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response AGNC Q1 2026 Earnings Solid EPS Beat Amid Stable Mortgage Markets FSEA Q3 2024 Earnings Modest Profit Amid Narrowing Margins SBLK Q1 2026 Earnings Strong Beat on EPS as Dry Bulk Market Improves Rexford Industrial Realty Q1 2026 Earnings Strong EPS Beat Amid Stable Operations PRMB Q1 2026 Earnings EPS Misses Estimates Stock Rises on Strategic Optimism VICR Q1 2026 Earnings EPS Surprises 1983 Above Estimates as Stock Declines Slightly